Putting the vasoactive effects of COX-2-derived prostanoids into clinical perspective.
Krötz
Florian
F
D000818:Animals; D051546:Cyclooxygenase 2 / Q000502:physiology*; D052246:Cyclooxygenase 2 Inhibitors / Q000494:pharmacology; D006801:Humans; D009638:Norepinephrine / Q000494:pharmacology; D011453:Prostaglandins / Q000502:physiology*; D014661:Vasoconstriction / Q000187:drug effects
D052246:Cyclooxygenase 2 Inhibitors; D011453:Prostaglandins; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D009638:Norepinephrine